Grey Matter Damage at the Earliest Phase of Multiple Sclerosis : a Longitudinal 7T MRI Study
Condition(s) studied
Investigational drug(s) / intervention(s)
MRI 7T: The imaging parameters will come from the 7 Tesla Siemens MRI
Study summary
The present study is an opportunity to assess grey matter damage at the earliest phase of Multiple Sclerosis (MS) allowing to a better understanding of its origins and its impact and disease severity. This study is a preliminary longitudinal study to precisely depict the kinetic of grey matter damage and the links with disease aggravation. Thirty MS patients without time and spatial dissemination criteria (only one symptomatic MRI lesion detected) but with oligoclonal bands detected on cerebro spinal fluid analysis will be included for a monocentric transversal MRI study at 7T to assess grey matter injury. Clinical and neuropsychological assessments will be performed in the population the same day of a multi-parametric MRI. A longitudinal clinical and MRI follow up will be performed during 2 years.
Eligibility
Primary outcome measure(s)
- number of cortical lesions — 2 hours
Cortical lesion detection on 7T MRI at baseline
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Assistance Publique Des Hopitaux de Marseille | Marseille | PACA |
More Assistance Publique Hopitaux De Marseille trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03659981 on ClinicalTrials.gov ↗ ← All trials in France